U.S. Life Sciences Stock News

Carpenter Technology (CRS) shares are in focus after the company reported record second quarter operating income, stronger aerospace and defense bookings, and raised its full year 2026 operating income guidance by 30% to 33%. See our latest analysis for Carpenter Technology. The latest results and guidance landed alongside a 1-day share price return of 2.4% to US$317.83, even though the 30-day share price return is a 6.1% decline. At the same time, the 1-year total shareholder return of 65.2%...

A class action lawsuit has been filed against Beyond Meat, alleging false or misleading statements related to asset impairments. The suit also challenges delays in the company’s financial reporting and the transparency of its disclosures. The legal action targets Beyond Meat’s executive decision making and communication with investors in recent reporting periods. For investors watching NasdaqGS:BYND, this lawsuit lands at a time when the stock has already seen sharp pressure. The share...

Huntington Ingalls Industries (HII) is back in focus after the USS John F. Kennedy aircraft carrier left its Newport News Shipbuilding division for sea trials, a key milestone on a complex, long-cycle naval contract. See our latest analysis for Huntington Ingalls Industries. Those carrier sea trials come on top of recent progress across HII, including completion of builder’s sea trials for USS Zumwalt and new long term engineering work under the ATSP5 contract, alongside leadership changes at...

In November 2025, uniQure reported that the FDA had informed the company that data from its Phase I/II AMT-130 gene therapy trial were not sufficient to support a Biologics License Application, leaving the timing of any filing uncertain. This FDA feedback places greater emphasis on the robustness of uniQure’s clinical data packages and could reshape perceptions of its gene therapy pipeline. We’ll now examine how the FDA’s stance on AMT-130’s Phase I/II data influences uniQure’s investment...

Ryan Specialty Holdings recently reported that its core business expanded through average organic revenue growth of 12.8% annually over the past two years, alongside strong long-term earnings per share growth and high free cash flow margins. This combination of internally driven revenue expansion and substantial free cash generation highlights Ryan Specialty’s ability to grow its operations while still returning capital to investors. Next, we’ll examine how Ryan Specialty’s strong organic...

Old National Bancorp completed a $450 million fixed income offering, adding a new layer of funding flexibility. Management also reported continued progress in integrating Bremer Bank into the broader Old National platform. These updates come alongside a recent share price of $24.43 for NasdaqGS:ONB, with the stock up 8.3% over the past month. For you as an investor, the combination of fresh financing and ongoing Bremer Bank integration provides more context around how Old National Bancorp...

In January 2026, Banner Corporation reported fourth-quarter and full-year 2025 results showing higher net interest income and net income, lower net charge-offs than a year earlier, continued share repurchases totaling 499,975 shares for US$31.49 million, and a regular quarterly dividend of US$0.50 per share payable on February 13, 2026. Beyond the headline earnings growth, the combination of rising net interest income, disciplined credit costs, and concurrent dividends and buybacks...

Applied Materials (NasdaqGS:AMAT) has received multiple analyst upgrades linked to rising global semiconductor capital investment. Analysts are pointing to record wafer fabrication equipment spending and stronger demand from major chipmakers, including Taiwan Semiconductor and Intel. New chip architectures such as Gate-All-Around transistors and Backside Power Delivery are cited as key drivers for equipment demand. Applied Materials is a major supplier of equipment, services, and software...

Why Praxis Precision Medicines is Back on Investors’ Radar Praxis Precision Medicines (PRAX) is drawing fresh attention after signaling plans to file two New Drug Applications for ulixacaltamide and relutrigine, both already granted Breakthrough Therapy Designation by the US Food and Drug Administration. See our latest analysis for Praxis Precision Medicines. Praxis shares have been volatile, with a 30 day share price return of 9.64% and a 90 day share price return of 72.54%. The 1 year total...

Why NorthWestern Energy Group is on investors’ radar NorthWestern Energy Group (NWE) has drawn attention after a solid recent share price move, with the stock showing gains over the past week, month, past 3 months, and year to date. For investors following regulated utilities, this recent performance raises questions about how the company’s current valuation lines up with its earnings profile and the stability of its electricity and natural gas operations. See our latest analysis for...

Peloton Interactive (NasdaqGS:PTON) is cutting 11% of its workforce, with many roles in engineering and technology. The layoffs are part of a US$100 million cost savings plan tied to a broader restructuring effort. The move reflects ongoing demand and brand challenges that continue to shape Peloton’s turnaround efforts. Peloton built its business around connected fitness hardware and subscription content, a model that drew intense consumer interest during peak at home workout trends. As...

Why Spire Stock Is On Investors’ Radar Today Spire (SR) is drawing attention after recent share performance data highlighted mixed short term moves alongside stronger multi year returns, prompting investors to reassess how the gas utility’s profile fits into their portfolios. See our latest analysis for Spire. At the current share price of $84.49, Spire’s recent 7 day share price return of 2.07% follows a softer 90 day share price return of a 3.79% decline. Its 1 year total shareholder return...

TAL Education Group (TAL) just delivered third quarter results that beat expectations, with 27% year over year revenue growth, a very large jump in net income, expanding margins, and a sizeable ongoing buyback program. See our latest analysis for TAL Education Group. TAL’s recent earnings beat and active buyback appear to have fed into solid momentum, with a 7 day share price return of 13.49% and a 30 day share price return of 10.53%. The 3 year total shareholder return of 87.32% contrasts...

In late January 2026, Gentex Corporation reported fourth-quarter 2025 results showing sales of US$644.4 million and net income of US$92.96 million, alongside new 2026–2027 revenue guidance and completion of a roughly 1.9% share repurchase program. Beyond auto-dimming mirrors, Gentex underscored its diversification by launching a newly re-designed Ops-Core FAST XP Helmet System for law enforcement and highlighting progress in driver monitoring and other advanced technologies. We’ll now...

NVR (NYSE:NVR) reported mixed fourth quarter results, with revenue and profitability lower than a year earlier. The company highlighted ongoing margin pressures in its homebuilding segment. NVR also reported a reduction in its backlog of homes. NVR, which focuses on homebuilding and mortgage banking, is operating in a housing market shaped by affordability challenges and higher land costs. These pressures are affecting its margins, even as the company continues to close homes and manage its...

Short interest in Constellation Brands (NYSE:STZ) has recently declined, but remains above the average level seen across its peer group. The shift suggests a change in positioning among traders, while still pointing to elevated expectations for volatility around the stock. Constellation Brands, the owner of major beer, wine, and spirits labels, sits at the intersection of consumer staples and discretionary spending. When you see a clear move in short interest for a company like this, it...

Kennametal stock triggered review Kennametal (KMT) has drawn investor attention after a period of mixed short term returns, along with stronger moves over the past 3 months and year. This has prompted a closer look at its recent fundamentals and valuation. See our latest analysis for Kennametal. The recent 90 day share price return of 55.05% and 1 year total shareholder return of 48.82% suggest that momentum has been building, even after a softer 1 day share price move and the latest close at...

Dividend and product news around Hubbell stock Hubbell (HUBB) recently drew fresh attention after unveiling its Aclara360 software platform and other grid automation advances at DTECH 2026, while also affirming a regular quarterly dividend of $1.42 per share. See our latest analysis for Hubbell. Against this backdrop, Hubbell’s recent product launches and dividend confirmation sit alongside steady share price strength, with a 30 day share price return of 5.38% and a 1 year total shareholder...

StoneCo (STNE) is back in focus as several major firms reiterate buy ratings ahead of its March 2, 2026 earnings report, with expectations for roughly 28% year-over-year earnings growth drawing investor attention. See our latest analysis for StoneCo. StoneCo's share price at US$16.14 reflects a mixed recent run, with a 9.9% 1 month share price return and a 15.1% 3 month share price decline, alongside a 76.0% 1 year total shareholder return that hints at strong underlying momentum over a...

Why Bath & Body Works Is Back in Focus After Its Consumer First Formula Update Bath & Body Works (BBWI) recently reported quarterly revenue of US$1.59b that was flat year on year and below analyst expectations, while unveiling its Consumer First Formula transformation plan. See our latest analysis for Bath & Body Works. The Consumer First Formula announcement came as the stock moved higher in the very short term, with a 1 day share price return of 5.16%. However, this sits against a 1 year...

In late January 2026, Merck confirmed a US$0.85 per-share quarterly dividend for the second quarter and walked away from Revolution Medicines acquisition talks after valuation disagreements, while moving ahead with oncology-focused investments and partnerships. Together with collaborations such as the Guardant Health companion diagnostics deal and a US$30 million Eikon Therapeutics stake, these moves highlight Merck’s preference for targeted partnerships over very large takeovers to expand...

Tapestry (NYSE:TPR) agreed to sell its Stuart Weitzman brand to Caleres in August 2025. The deal reshapes Tapestry's brand portfolio, which also includes Coach and Kate Spade. The transaction points to a sharpened focus on core labels and a different approach to footwear within the group. Tapestry, the parent company of Coach and Kate Spade, operates in the accessible luxury and premium accessories space, where brand focus and clear positioning play an important role in long term value...

Why Canadian Solar’s 2025 Profit Guidance Matters Canadian Solar (CSIQ) expects 2025 net profit attributable to shareholders between RMB 900 million and RMB 1,100 million, a 60% to 51% year on year decline compared with 2024, which puts profitability in sharper focus for investors. See our latest analysis for Canadian Solar. The profit warning has arrived alongside a sharp reset in sentiment, with Canadian Solar’s 1 day share price return of 3.26% decline and 30 day share price return of...

Archer Aviation (NYSE:ACHR) has reached an agreement with the Government of Serbia to serve as the official air taxi provider for EXPO 2027 in Belgrade. The partnership includes options for fleet sales and potential industrial collaboration connected to Archer's eVTOL aircraft. The arrangement is expected to position Archer at the center of EXPO 2027 transportation plans, with global visitors as a key audience. For investors watching Archer Aviation at a share price of $7.19, this Serbia...